Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Non-Current Assets (2018 - 2025)

Black Diamond Therapeutics' Other Non-Current Assets history spans 6 years, with the latest figure at $73000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 91.09% year-over-year to $73000.0; the TTM value through Dec 2025 reached $73000.0, down 91.09%, while the annual FY2025 figure was $73000.0, 91.09% down from the prior year.
  • Other Non-Current Assets reached $73000.0 in Q4 2025 per BDTX's latest filing, down from $827000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.2 million in Q1 2021 to a low of $73000.0 in Q4 2025.
  • Average Other Non-Current Assets over 3 years is $807636.4, with a median of $824000.0 recorded in 2025.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 2123.64% in 2021, then crashed 91.09% in 2025.
  • A 3-year view of Other Non-Current Assets shows it stood at $1.2 million in 2021, then tumbled by 33.03% to $819000.0 in 2024, then plummeted by 91.09% to $73000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Other Non-Current Assets are $73000.0 (Q4 2025), $827000.0 (Q3 2025), and $824000.0 (Q2 2025).